Thus, human NPH as part of a multiple injection regimen should be used for intermediate-acting insulin effect in GDM. [14] At present there are no data on the use of detemir in pregnancy.

By inhibiting DPP4, vildagliptin causes an increase in glucagon like peptide-1 (GLP-1), an intestinal hormone that aids in glucose homeostasis and insulin secretion. The manufacturer of ...